FDA-Cleared Light Therapy Devices for Psoriasis Treatment | Wholesale Supplier_51
FDA-Cleared Light Therapy Devices for Psoriasis Treatment
For patients in humid climates like Southeast Asia or arid regions like the Middle East, our medical UVB devices provide targeted psoriasis relief without skin irritation. Clinically proven to reduce plaques by 75% in 8 weeks, these systems address the limitations of topical treatments. European-designed units feature adjustable wavelength settings for different skin types.
How Our Phototherapy Outperforms Traditional Treatments
| Feature | Our UVB System | Conventional Options |
|---|---|---|
| Treatment Time | 3-5 minutes/session | 15-20 minutes |
| Side Effects | Less than 2% redness | 15% irritation rate |
| Portability | 23" compact design | Bulky equipment |
Precision Manufacturing Process
Our automated production line includes 7 quality verification stages from component soldering to final output testing. Each unit undergoes 48-hour continuous operation simulation before packaging.
Quality Assurance Protocols
- ISO 13485 certified manufacturing facility
- Third-party lab tested for IEC 60601-1 safety
- 36-month performance warranty
Global Logistics Solutions
MOQ: 50 units (mix & match models allowed). Standard delivery within 15 working days via DDP terms. Custom documentation preparation for FDA/CE markets available.


"After testing 3 suppliers, their 311nm UVB system showed 92% improvement for our clinic patients." - Dr. Schmidt, Berlin Dermatology Center
Currently serving 178 medical facilities across 35 countries with 12,000 units shipped annually. All transactions protected by Escrow payment options.
Next Steps for Medical Purchasers
- Download product catalog with technical drawings
- Request sample unit with clinical trial data
- Schedule video consultation with our engineers
Pro Tip: Include your country‘s voltage requirements (110V/220V) when requesting quotes to accelerate the process.